Arcellx Inc (ACLX)
$85.34 -$1.64 (-1.89%) 10:01 AM 12/12/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$4.57B -
Day's Range
$85.03 - $87.91 -
Volume
471,933 -
52 Week Low / High
$46.42 - $107.37 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
- 13
- Strong Buy
- 6
- Buy
- 0
- Hold
- 0
- Sell
- 0
- Strong Sell
- $51.64
- Target Price
Company News
-
Is Boston Scientific (BSX) Stock Outpacing Its Medical Peers This Year? — Oct 9th, 2024
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Has Boston Scientific (BSX) been one of those stocks this year? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector shoul...
-
Is Boston Scientific (BSX) Stock Outpacing Its Medical Peers This Year? — Oct 9th, 2024
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Has Boston Scientific (BSX) been one of those stocks this year? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector shoul...
-
ACLX Stock Earnings: Arcellx Beats EPS, Beats Revenue for Q2 2024 — Aug 9th, 2024
ACLX stock results show that Arcellx beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024....
-
Is Boston Scientific (BSX) Stock Outpacing Its Medical Peers This Year? — Oct 9th, 2024
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Has Boston Scientific (BSX) been one of those stocks this year? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector shoul...
-
Arcellx And Legend Bio Trade Jabs In Multiple Myeloma. But Only One Pulls Ahead. — Dec 9th, 2024
Arcellx stock reversed lower Monday on positive results for its rival to Legend Biotech's multiple myeloma treatment, Carvykti. Continue reading View comments...
-
Is Boston Scientific (BSX) Stock Outpacing Its Medical Peers This Year? — Oct 9th, 2024
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Has Boston Scientific (BSX) been one of those stocks this year? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector shoul...
-
Arcellx And Legend Bio Trade Jabs In Multiple Myeloma. But Only One Pulls Ahead. — Dec 9th, 2024
Arcellx stock reversed lower Monday on positive results for its rival to Legend Biotech's multiple myeloma treatment, Carvykti. Continue reading View comments...
-
Is Boston Scientific (BSX) Stock Outpacing Its Medical Peers This Year? — Oct 9th, 2024
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Has Boston Scientific (BSX) been one of those stocks this year? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector shoul...
-
Arcellx And Legend Bio Trade Jabs In Multiple Myeloma. But Only One Pulls Ahead. — Dec 9th, 2024
Arcellx stock reversed lower Monday on positive results for its rival to Legend Biotech's multiple myeloma treatment, Carvykti. Continue reading View comments...
-
Is Boston Scientific (BSX) Stock Outpacing Its Medical Peers This Year? — Oct 9th, 2024
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Has Boston Scientific (BSX) been one of those stocks this year? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector shoul...
-
Is Boston Scientific (BSX) Stock Outpacing Its Medical Peers This Year? — Oct 9th, 2024
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Has Boston Scientific (BSX) been one of those stocks this year? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector shoul...
-
Is Boston Scientific (BSX) Stock Outpacing Its Medical Peers This Year? — Oct 9th, 2024
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Has Boston Scientific (BSX) been one of those stocks this year? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector shoul...
Similar Stocks
Portfolio
Comprised of 1 portfolios